Skip to main content
SpringerLink
Log in

Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin

  • THE CUTTING EDGE: RESEARCH UPDATE
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee A, Levine M (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Nejm 349:146–153

    Article  CAS  PubMed  Google Scholar 

  2. Ea A, Barba M, Rohilla S et al (2014) Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer (Review). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006650.pub4.www.cochranelibrary.com

    Article  Google Scholar 

  3. Lee AYY, Kamphuisen PW, Meyer G et al (2015) Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer. JAMA 314:677. https://doi.org/10.1001/jama.2015.9243

    Article  CAS  PubMed  Google Scholar 

  4. Verso M, Agnelli G, Prandoni P (2015) Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer. Intern Emerg Med 10:651–656. https://doi.org/10.1007/s11739-015-1233-5

    Article  PubMed  Google Scholar 

  5. Raskob GE, van Es N, Verhamme P et al (2018) Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 378:615–624. https://doi.org/10.1056/NEJMoa1711948

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Fondazione IRCSS Ca’ Granda, Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milano, Italy

    Elisa Maria Fiorelli

  2. Department of Gastroenterology and Endoscopy, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico and Department of Pathophysiology and Organ Transplant, Università degli Studi di Milano, Milan, Italy

    Roberta Elisa Rossi

Authors
  1. Elisa Maria Fiorelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta Elisa Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

GrAM (Gruppo di Autoformazione Metodologica)

Corresponding author

Correspondence to Elisa Maria Fiorelli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with humans and animals performed by any of the authors.

Informed consent

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiorelli, E.M., Rossi, R.E. & GrAM (Gruppo di Autoformazione Metodologica). Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin. Intern Emerg Med 13, 1089–1091 (2018). https://doi.org/10.1007/s11739-018-1886-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-018-1886-y

Keywords

Search

Navigation